| Nanocarriers as potential targeted drug delivery for cancer therapy G Singhvi, VK Rapalli, S Nagpal, SK Dubey, RN Saha Nanoscience in Medicine Vol. 1, 51-88, 2020 | 53 | 2020 |
| Exploring the interplay between drug release and targeting of lipid-like polymer nanoparticles loaded with doxorubicin T Kovshova, N Osipova, A Alekseeva, J Malinovskaya, A Belov, A Budko, ... Molecules 26 (4), 831, 2021 | 34 | 2021 |
| A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release S Nagpal, S Braner, H Modh, AXX Tan, MP Mast, K Chichakly, V Albrecht, ... European Journal of Pharmaceutics and Biopharmaceutics 153, 257-272, 2020 | 24 | 2020 |
| Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical data H Modh, DJ Fang, YH Ou, JNN Yau, T Kovshova, S Nagpal, J Knoll, ... International Journal of Pharmaceutics 608, 121073, 2021 | 22 | 2021 |
| Current clinical status of new COVID-19 vaccines and immunotherapy D Nagpal, S Nagpal, D Kaushik, H Kathuria Environmental Science and Pollution Research 29 (47), 70772-70807, 2022 | 14 | 2022 |
| Bioanalytical strategies in drug discovery and development A Thakur, Z Tan, T Kameyama, E El-Khateeb, S Nagpal, S Malone, ... Drug Metabolism Reviews 53 (3), 434-458, 2021 | 12 | 2021 |
| Improved melatonin delivery by a size-controlled polydopamine nanoformulation attenuates preclinical diabetic retinopathy MN Sardoiwala, S Nagpal, B Bhatt, S Roy Choudhury, S Karmakar Molecular Pharmaceutics 20 (6), 2899-2910, 2023 | 7 | 2023 |
| Nanoscience in Medicine G Singhvi, VK Rapalli, S Nagpal, SK Dubey, RN Saha Cham: Springer International Publishing, 51-88, 2020 | 5 | 2020 |
| A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars S Nagpal, J Png Yi Jie, J Malinovskaya, T Kovshova, P Jain, S Naik, ... ACS nano 18 (8), 6162-6175, 2024 | 2 | 2024 |
| Pharmaceutical Applications of Gellan Gum S Nagpal, SK Dubey, VK Rapalli, G Singhvi Natural Polymers for Pharmaceutical Applications, 87-109, 2019 | 2 | 2019 |
| A bio-predictive release assay for liposomal prednisolone phosphate S Nagpal, J Png, L Kahouadji, MG Wacker Journal of Controlled Release 374, 61-75, 2024 | 1 | 2024 |
| Revisiting nanomedicine design strategies for follow-on products: A model-informed approach to optimize performance S Nagpal, T Palaniappan, JW Wang, MG Wacker Journal of Controlled Release 376, 1251-1270, 2024 | | 2024 |
| A DESIGN CONVERSED OPTIMIZATION AND DECONVOLUTION (DeCODe) MODELING FRAMEWORK TO STREAMLINE NANOMEDICINE MANUFACTURE S NAGPAL | | 2024 |
| A Systematic Review on Analytical Methods to Determine Chiral and Achiral Forms of Venlafaxine and its Metabolite O-desmethylvenlafaxine SK Dubey, M Jindal, S Nagpal, RN Saha, G Singhvi, A Anand, KV Krishna Current Pharmaceutical Analysis 16 (5), 474-486, 2020 | | 2020 |
| Injectable Drug Delivery Systems of Active Ingredient Revisited: In Vitro-In Vivo Relationships Using Human Clinical Data H Modh, DJ Fang, YH Ou, JNN Yau, T Kovshova, S Nagpal, J Knoll, ... | | |
